Abstract #1530
            Phospholipidosis affects Hepatobiliary Function as assessed by Gadoxetate DCE-MRI
                      Stephen Lenhard                     1                    , Debra Paul                     2                    , 						Mally Lev                     3                    , Lindsey Webster                     4                    , 						Christopher Goulbourne                     5                    , Richard Peterson                     5                    , 						Richard Miller                     6                    , and Beat Jucker                     1          
            
            1
           
           Pre-clinical and Translational Imaging, 
						GlaxoSmithKline, King of Prussia, Pennsylvania, United 
						States,
           
            2
           
           LAS, 
						GlaxoSmithKline, King of Prussia, Pennsylvania, United 
						States,
           
            3
           
           DMPK, 
						GlaxoSmithKline, King of Prussia, Pennsylvania, United 
						States,
           
            4
           
           DMPK, 
						GlaxoSmithKline, Research Triangle Park, North Carolina, 
						United States,
           
            5
           
           Safety 
						Assesment, GlaxoSmithKline, Research Triangle Park, 
						North Carolina, United States,
           
            6
           
           LAS, 
						GlaxoSmithKline, Research Triangle Park, North Carolina, 
						United States
          
            
          Phospholipidosis (PLD) is a generalized condition in 
						humans and animals characterized by an intracellular 
						accumulation of phospholipids. Using a clinically 
						available liver specific MRI contrast agent 
						(Eovist;Gadoxetate) we performed hepatobiliary Dynamic 
						Contrast Enhanced MRI (DCE-MRI) to determine if 
						Gadoxetate kinetic changes could be detected with a 
						known inducer of hepatic PLD (Amiodarone). Amiodarone 
						induced a significant decrease in Gadoxetate washout 
						rate which returned to baseline levels after the 2 week 
						washout of Amiodarone. Gadoxetate DCE MRI of liver 
						function may be a useful technique to assess hepatic 
						functional consequences of PLD for compounds found to 
						induce PLD.
         
				
					How to access this content:
					For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
					After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
					After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
					Click here for more information on becoming a member.